Providing viral vectors for neuroscience research
BRAIN Viral Vector Services and Distribution Core
This study is all about helping scientists who are exploring how the brain works and what goes wrong in brain disorders by providing them with special tools called viral vectors, making it easier and more affordable for them to do their important research.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10918235 on NIH RePORTER |
What this research studies
This research focuses on creating and distributing high-quality viral vectors that are essential for neuroscientists studying brain circuits and disorders. The BRAIN Viral Vector Service and Distribution Core will assist researchers by producing adeno-associated viruses (AAV) and other viral tools, ensuring they are affordable and effective for various applications in neuroscience. The core will also provide support in vector design and optimization, enhancing the performance of these tools in live animal studies. By collaborating with researchers, the core aims to advance the understanding of neural connections and brain diseases.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals with neurological conditions that could be targeted by gene therapies using viral vectors.
Not a fit: Patients with conditions unrelated to brain disorders or those not eligible for gene therapy approaches may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the tools available for studying and treating brain disorders.
How similar studies have performed: Previous research has shown success in using viral vectors for gene therapy in various neurological conditions, indicating a promising approach.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Ritola, Kimberly — Univ of North Carolina Chapel Hill
- Study coordinator: Ritola, Kimberly
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.